A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus | MicrobiomeTrials
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-12-03Est. Completion: 2026-07
Enrollment target: 24 participants
Locations
Investigative Site, Beverly Hills, California, United States
Investigative Site, Clearwater, Florida, United States
Investigative Site, DeBary, Florida, United States
Investigative Site, Tampa, Florida, United States
Investigative Site, Indianapolis, Indiana, United States
Investigative Site, Flint, Michigan, United States
Investigative Site, Troy, Michigan, United States
Investigative Site, Saint Joseph, Missouri, United States
Investigative Site, Fairport, New York, United States
Investigative Site, Memphis, Tennessee, United States
Investigative Site, Allen, Texas, United States
Investigative Site, Arlington, Texas, United States
Investigative Site, Colleyville, Texas, United States
Investigative Site, Haskovo, Bulgaria
Investigative Site, Plovdiv, Bulgaria
Investigative Site, Sofia, Bulgaria
Investigative Site, Paris, France
Investigative Site, Toulouse, France
Other microbiome trials you might be interested in